 |
市场调查报告书
商品编码
1608712
兽用抗生素市场：依药物类型、剂型、动物类型、地区分类Veterinary Antibiotics Market, By Drug Type, By Dosage Form, By Animal Type, By Geography |
||||||
预计2024年兽用抗生素市场规模为40.2亿美元，预计2031年将达52.3亿美元，2024年至2031年复合年增长率为3.8%。
| 分析范围 | 分析详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 市场规模（2024年） | 40.2亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测期复合年增长率（2024-2031）： | 3.80% | 预计金额（2031年） | 52.3亿美元 |
由于动物保健成本的增加和通用感染疾病的流行，兽用抗生素市场正在经历显着增长。畜牧业的成长，特别是在已开发地区，也推动了对抗生素的需求，以预防和治疗伴同性动物的各种感染疾病。此外，生活方式的改变和对富含动物源蛋白质的饮食的日益关注正在促进世界各地的肉类产量。大规模畜牧生产需要适当使用抗生素来促进肉类用动物生长并预防疾病。
市场动态
食品消费的增加可能会推动兽用抗生素市场的成长。 2019年，根据联合国粮食及农业组织的数据，2020年至2030年间，全球肉类产量预计将成长约15%。然而，畜牧业过度使用和滥用抗生素导致了抗生素抗药性，阻碍了市场成长。包括噬菌体和益生菌在内的替代治疗方案为市场相关人员带来了重大机会。开发中国家兽医医疗基础设施的成长可能会在不久的将来为抗生素製造商开闢新的途径。
本报告的主要特点
本报告对全球兽用抗生素市场进行了详细分析，以 2023 年为基准年估计了预测期内（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球兽用抗生素市场的主要企业进行了分析。
本报告涵盖的主要企业包括 Merck &Co., Inc.、Ceva Sante Animale、Zoetis、Boehringer Ingelheim International GmbH、Dechra Pharmaceuticals、Elanco Animal Health Incorporated、Virbac SA、Bimeda, Inc.、Vetoquinol、Zydus A Amal Health. Inovet、Calier 和Phibro 动物保健公司。
该报告的见解将帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球兽用抗生素市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过分析全球动物抗生素市场时所使用的各种策略矩阵来促进决策。
目录
第一章 分析目的与前提
- 分析目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特的分析
- 企业合併(M&A) 场景
- 流行病学
第三章 市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
- 流行病学
第四章兽用抗生素市场：依药物类型，2019-2031（十亿美元）
- Aminoglycosides
- β-内酰胺类抗生素
- 氯霉素
- Fluoroquinolones
- 糖肽
- 林可酰胺
- 大环内酯
- 多粘菌素
- 四环霉素
- 其他的
第五章兽用抗生素市场：依剂型分类，2019-2031（十亿美元）
- 粉末
- 解决方案
- 注射
- 其他的
第六章 兽用抗生素市场：依动物类型，2019-2031（十亿美元）
- 伴同性动物
- 狗
- 猫科动物
- 家畜
- 牛
- 羊
- 猪肉
- 其他（家禽等）
第七章 兽用抗生素市场：依地区划分，2019-2031（十亿美元）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第八章 竞争格局
- Merck & Co., Inc.
- Ceva Sante Animale
- Zoetis
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals
- Elanco Animal Health Incorporated
- Virbac SA
- Bimeda, Inc.
- Vetoquinol
- Zydus Animal Health
- Blacksmith Medicines
- Inovet
- Calier
- Phibro Animal Health Corporation
第九章 分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第10章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Veterinary antibiotics market is estimated to be valued at USD 4.02 Bn in 2024 and is expected to reach USD 5.23 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | 4.02 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 3.80% | 2031 Value Projection: | 5.23 Bn |
Veterinary antibiotics market has witnessed significant growth due to rising animal healthcare expenditure and increasing prevalence of zoonotic diseases. Growing animal adoption, particularly in developed regions, has also boosted demand for antibiotics to prevent and treat various infections in companion animals. Moreover, changing lifestyles and increasing focus on protein-rich diets from animal sources have revved up meat production across the globe. Large scale livestock production practices necessitate the proper use of antibiotics to promote growth and prevent diseases in animals reared for meat consumption.
Market Dynamics
Rising consumption of livestock-derived food products can drive the veterinary antibiotics market growth. In 2019, according to the United Nations Food and Agriculture Organization, global meat production is projected to grow approximately 15% in the period between 2020 and 2030. However, overuse and misuse of antibiotics in the livestock sector has led to antibiotic resistance, thus, hampering the market growth. Alternative treatment options including bacteriophages and probiotics present significant opportunities for market players. Growing veterinary healthcare infrastructure in developing nations can create new avenues for antibiotics manufacturers in the near future.
Key features of the study
This report provides in-depth analysis of the global veterinary antibiotics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary antibiotics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc., Ceva Sante Animale, Zoetis, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals, Elanco Animal Health Incorporated, Virbac S.A., Bimeda, Inc., Vetoquinol, Zydus Animal Health, Blacksmith Medicines, Inovet, Calier, and Phibro Animal Health Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global veterinary antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary antibiotics market
Market Segmentation
- By Drug Type Insights (Revenue, USD Bn, 2019 - 2031)
- Aminoglycosides
- B-Lactam Antibiotics
- Chloramphenicol
- Fluoroquinolones
- Glycopeptides
- Lincosamides
- Macrolides
- Polymixins
- Tetracyclines
- Others
- By Dosage Form Insights (Revenue, USD Bn, 2019 - 2031)
- Powder
- Solutions
- Injections
- Others
- By Animal Type Insights (Revenue, USD Bn, 2019 - 2031)
- Companion
- Canine
- Feline
- Livestock
- Bovine
- Ovine
- Porcine
- Others (Poultry, etc.)
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck & Co., Inc.
- Ceva Sante Animale
- Zoetis
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals
- Elanco Animal Health Incorporated
- Virbac S.A.
- Bimeda, Inc.
- Vetoquinol
- Zydus Animal Health
- Blacksmith Medicines
- Inovet
- Calier
- Phibro Animal Health Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Veterinary Antibiotics Market, By Drug Type
- Veterinary Antibiotics Market, By Dosage Form
- Veterinary Antibiotics Market, By Animal Type
- Veterinary Antibiotics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Epidemiology
4. Veterinary Antibiotics Market, By Drug Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Aminoglycosides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- B-Lactam Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Chloramphenicol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Fluoroquinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Glycopeptides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Lincosamides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Macrolides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Polymixins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Tetracyclines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Veterinary Antibiotics Market, By Dosage Form, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Veterinary Antibiotics Market, By Animal Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Companion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Canine
- Feline
- Livestock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Bovine
- Ovine
- Porcine
- Others (Poultry, etc.)
7. Veterinary Antibiotics Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zoetis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dechra Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elanco Animal Health Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bimeda, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetoquinol
- Zydus Animal Health
- Blacksmith Medicines
- Inovet
- Calier
- Phibro Animal Health Corporation
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
动物疫苗市场：依产品、动物类型、给药途径、通路、地区、机会、预测，2017-2031
伴同性动物疫苗市场：依产品类型、动物类型、通路划分 - 全球预测 2025-2030 年
动物/牲畜疫苗市场：按类型、疾病、技术分类 - 2025-2030 年全球预测
动物疫苗市场：依产品类型 - 2025-2030 年全球预测
家禽疫苗市场：按疾病类型、技术和剂型划分 - 全球预测 2025-2030
梭菌疫苗市场：依动物类型、通路划分 - 全球预测 2025-2030
猪疫苗市场：按适应症、技术、最终用户划分 - 2025-2030 年全球预测
狗疫苗市场：按疫苗类型、按技术、按最终用户、按分销管道、按应用、按年龄组、按狗大小 - 2025-2030 年全球预测
兽用抗生素市场规模、份额和趋势分析报告：2025-2030 年按动物类型、药物类别、剂型、地区和细分市场预测
2031 年亚太地区家禽疫苗市场预测 - 区域分析 - 按类型、技术、剂型、疾病、给药途径和最终用户